TB Alliance: Putting science to work for a faster TB cure

Follow Us:

Board of Directors

TB Alliance is governed by a Board of Directors, representing global perspectives and expertise in diverse areas of interest that ensure the success and sustainability of the organization.

TB Alliance is a not-for-profit organization governed by a Board of Directors. The Board assumes fiduciary responsibility for the TB Alliance and guides its strategy, actions, and budget. An elected member of the Stakeholders Association serves as a member of the Board of Directors.

Dr. Carlos Morel | Chairman Director, Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation (FIOCRUZ)
Dr. Bruce Carter Retired, Former executive at Immune Design
Dr. Jan Gheuens Deputy Director, TB Drugs, Global Health, Bill & Melinda Gates Foundation
Mr. Karl Hofmann President and Chief Executive Officer, Population Services International
Mr. David Norton Formerly, Company Group Chairman, Global Pharmaceuticals, Johnson & Johnson
Dr. Mario Raviglione Director of the Global TB Programme, World Health Organization
Mr. Paul Sekhri President, CEO and Director, Lycera Corp
Ms. Shalini Sharp Chief Financial Officer and Senior Vice President, Finance, Ultragenyx
Dr. Melvin Spigelman President & Chief Executive Officer, Global Alliance for TB Drug Development
Dr. Debrework Zewdie Senior Advisor, President's Office Special Envoy, World Bank